Idiopathic pulmonary fibrosis: An EU patient perspective survey

Current Respiratory Medicine Reviews

Volumn 9, Issue 2, 2013, Pages 112-119

  Giot, Christophe ^a   Maronati, Manuela ^a   Becattelli, Ian ^b   Schoenheit, Gadi ^b  

^a InterMune International AG   (Switzerland)

^b DoxaPharma Srl   (Italy)

Author keywords

Depression; Emotional support; Idiopathic pulmonary fibrosis; Patient feelings; Patient perspective survey; Social isolation

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CONFUSION; COPING BEHAVIOR; DAILY LIFE ACTIVITY; DEPRESSION; EMOTION; FATIGUE; FIBROSING ALVEOLITIS; FOLLOW UP; HEALTH SURVEY; HUMAN; INTERVIEW; INTROSPECTION; LONELINESS; PATIENT ATTITUDE; PATIENT REFERRAL; PHYSICIAN; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; QUALITATIVE ANALYSIS; QUALITY OF LIFE; SOCIAL ISOLATION; TRUST; WELLBEING;

EID: 84882787965     PISSN: 1573398X     EISSN: 18756387     Source Type: Journal    
DOI: 10.2174/1573398X113099990010     Document Type: Article

References (13)

1. Raghu G, Collard HR, Egan JJ, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med 2011; 183 (6): 788-824.
2. Schoenheit G, Becattelli I, Cohen AH. Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients. Chron Respir Dis 2011; 8 (4): 225-31.
3. Krishnan V, McCormack MC, Mathai SC, et al. Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis. Chest 2008; 134 (4): 693-8.
4. Mermigkis C, Stagaki E, Amfilochiou A, et al. Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis. Med Princ Pract 2009; 18 (1): 10-5.
5. Swigris JJ, Stewart AL, Gould MK, et al. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 2005; 3: 61.
6. European public assessment report for Esbriet® pirfenidone [cited 2012 Jul 19]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002154/WC500102979.pdf
7. De Vries J, Kessels BL, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 2001; 17 (5): 954-61.
8. Martinez TY, Pereira CA, dos Santos ML, et al. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest 2000; 117 (6): 1627-32.
9. Swigris JJ, Kuschner WG, Jacobs SS, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005; 60 (7): 588-94.
10. Elfferich MD, De VJ, Drent M. Type D or 'distressed' personality in sarcoidosis and idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28 (1): 65-71.
11. Verma G, Marras T, Chowdhury N, et al. Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis. Can Respir J 2011; 18 (5): 283-7.
12. Collard HR, Tino G, Noble PW, et al. Patient experiences with pulmonary fibrosis. Respir Med 2007; 101 (6): 1350-4.
13. The International Chamber of Commerce (ICC)/The European Society for Opinion and Market Research (ESOMAR) International Code on Market and Social Research [cited 2012 Jul 19]. Available from: http://www.esomar.org/uploads/public/knowledge-and-standards/codes-and-guidelines/ICCESOMAR_Code_English_pdf